Your browser doesn't support javascript.
loading
Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus.
Hasni, Sarfaraz; Temesgen-Oyelakin, Yenealem; Davis, Michael; Chu, Jun; Poncio, Elaine; Naqi, Mohammad; Gupta, Sarthak; Wang, Xinghao; Oliveira, Christopher; Claybaugh, Dillon; Dey, Amit; Lu, Shajia; Carlucci, Philip; Purmalek, Monica; Manna, Zerai G; Shi, Yinghui; Ochoa-Navas, Isabel; Chen, Jinguo; Mukherjee, Amrita; Han, Kyu Lee; Cheung, Foo; Koroleva, Galina; Belkaid, Yasmine; Tsang, John S; Apps, Richard; Thomas, Donald E; Heller, Theo; Gadina, Massimo; Playford, Martin P; Li, Xiaobai; Mehta, Nehal N; Kaplan, Mariana J.
Afiliación
  • Hasni S; Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA sarfaraz.hasni@nih.gov.
  • Temesgen-Oyelakin Y; Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Davis M; Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Chu J; Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Poncio E; Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Naqi M; Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Gupta S; Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA.
  • Wang X; Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA.
  • Oliveira C; Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA.
  • Claybaugh D; Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA.
  • Dey A; Section of Inflammation and Cardiometabolic Diseases, National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA.
  • Lu S; Translational Immunology Section, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
  • Carlucci P; Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA.
  • Purmalek M; Systemic Autoimmunity Branch/NIAMS, National Institutes of Health, Bethesda, Maryland, USA.
  • Manna ZG; Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Shi Y; Office of the Clinical Director, NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA.
  • Ochoa-Navas I; Lupus Clinical Trials Unit, Office of the Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Chen J; National Institutes of Health, Bethesda, Maryland, USA.
  • Mukherjee A; National Institutes of Health, Bethesda, Maryland, USA.
  • Han KL; National Institutes of Health, Bethesda, Maryland, USA.
  • Cheung F; National Institutes of Health, Bethesda, Maryland, USA.
  • Koroleva G; National Institutes of Health, Bethesda, Maryland, USA.
  • Belkaid Y; Metaorganism Immunity Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
  • Tsang JS; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, National Institutes of Health, Bethesda, Maryland, USA.
  • Apps R; NIH Center for Human Immunology, National Institutes of Health, Bethesda, Maryland, USA.
  • Thomas DE; National Institutes of Health, Bethesda, Maryland, USA.
  • Heller T; Arthritis and Pain Associates of PG County, Greenbelt, Maryland, USA.
  • Gadina M; NIDDK, National Institutes of Health, Bethesda, Maryland, USA.
  • Playford MP; NIAMS, National Institutes of Health, Bethesda, Maryland, USA.
  • Li X; National Heart Lung and Blood Institute, Bethesda, Maryland, USA.
  • Mehta NN; Biostatistics and Clinical Epidemiology Service, National Institutes of Health Clinical Center, Bethesda, Maryland, USA.
  • Kaplan MJ; National Institutes of Health, Bethesda, Maryland, USA.
Ann Rheum Dis ; 2022 Aug 01.
Article en En | MEDLINE | ID: mdl-35914929
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Ann Rheum Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Ann Rheum Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos